These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8138963)
1. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes. Echizen H; Mochizuki K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963 [TBL] [Abstract][Full Text] [Related]
2. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes. Echizen H; Kawasaki H; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1993 Mar; 264(3):1425-31. PubMed ID: 8450476 [TBL] [Abstract][Full Text] [Related]
3. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition. Marathe PH; Shen DD; Nelson WL Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280 [TBL] [Abstract][Full Text] [Related]
4. Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans. Echizen H; Tanizaki M; Tatsuno J; Chiba K; Berwick T; Tani M; Gonzalez FJ; Ishizaki T Drug Metab Dispos; 2000 Aug; 28(8):937-44. PubMed ID: 10901704 [TBL] [Abstract][Full Text] [Related]
5. Human pharmacokinetics and metabolism of disopyramide enantiomers. Le Corre P; Gibassier D; Sado P; Le Verge R Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885 [TBL] [Abstract][Full Text] [Related]
6. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomes. Kim M; Shen DD; Eddy AC; Nelson WL; Roskos LK Drug Metab Dispos; 1993; 21(2):309-17. PubMed ID: 8097702 [TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: comparison with in vivo data. Le Corre P; Ratanasavanh D; Chevanne F; Gibassier D; Sado P; Le Verge R; Guillouzo A Chirality; 1991; 3(5):405-11. PubMed ID: 1756095 [TBL] [Abstract][Full Text] [Related]
9. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. Cook CS; Karim A; Sollman P Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395 [TBL] [Abstract][Full Text] [Related]
10. Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide. Zhang L; Fitzloff JF; Engel LC; Cook CS Xenobiotica; 2001 Feb; 31(2):73-83. PubMed ID: 11407536 [TBL] [Abstract][Full Text] [Related]
11. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective disposition and metabolism of disopyramide in pediatric patients. Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088 [TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
14. [Stereoselectivity in N-dealkylation of disopyramide enantiomers in mouse hepatic microsomes]. Kiriyama A; Morita K; Shimakawa H; Yokoyama T Yakugaku Zasshi; 1992 Jan; 112(1):61-4. PubMed ID: 1578345 [TBL] [Abstract][Full Text] [Related]
15. Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate. Suzuki A; Iida I; Tanaka F; Akimoto M; Fukushima K; Tani M; Ishizaki T; Chiba K Drug Metab Dispos; 1999 Nov; 27(11):1254-9. PubMed ID: 10534309 [TBL] [Abstract][Full Text] [Related]
16. Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes. Itoh K; Nishiya Y; Takasaki W; Adachi M; Tanaka Y Chirality; 2006 Aug; 18(8):592-8. PubMed ID: 16642492 [TBL] [Abstract][Full Text] [Related]
17. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients. Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes. Wienkers LC; Allievi C; Hauer MJ; Wynalda MA Drug Metab Dispos; 1999 Nov; 27(11):1334-40. PubMed ID: 10534319 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients. Aso R; Ohashi K; Katoh T; Ogata H Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]